| Non-Cutaneous Melanoma studied in …STUDIED_INderived200 of 312show all (up to 200) |
|---|
| → studied in | NCT07576725Phase 2 · not yet recruiting Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04462406Phase 2 · active not recruiting Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04511013Phase 2 · recruiting A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05524935Phase 2 · active not recruiting Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05607095Phase 1 · recruiting A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07804186Phase 3 · recruiting Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00937937Phase 2 · active not recruiting Dinaciclib in Treating Patients With Stage IV Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02678572Phase 3 · completed Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Ocular Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05546827Phase 2 · recruiting Preoperative Radiotherapy and Immunotherapy for Sinonasal and Anorectal Mucosal Melanoma · condition mapped ALIAS · 312 trials mapped (101 active) | — | — | Sinonasal Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05903937Phase 1 · not yet recruiting Locoregional Administration of TIL and Lymphodepletion in Patients With Melanoma and Liver Metastases · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06070012Phase 2 · recruiting Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07183852Phase 1 · not yet recruiting Locoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic Melanoma · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07400302Phase 2 · recruiting Sintilimab Combined With Chemotherapy for Adjuvant Treatment of Mucosal Melanoma After Surgery · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07803562Phase 2 · not yet recruiting Low Dose Dexamethasone for the Prevention of Cytokine Release Syndrome Associated With Tebentafusp · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07076550Phase 1 · terminated A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02506153Phase 3 · active not recruiting Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Non-Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04318717Phase 2 · recruiting Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma · condition mapped ALIAS · 312 trials mapped (101 active) | — | — | Head and Neck Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03025256Phase 1 · active not recruiting Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease · condition mapped ALIAS · 312 trials mapped (101 active) | — | — | Meningeal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07338968enrolling by invitation A Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal Melanoma · condition mapped ALIAS · 312 trials mapped (101 active) | — | — | Choroid Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07636785Phase 1/Phase 2 · recruiting A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05308901Phase 2 · terminated Lenvatinib Plus Pembrolizumab In Patients With Immune Checkpoint Inhibitor Naïve Metastatic Uveal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07414979Phase 1 · not yet recruiting Phase 1 Study Of Intrathecal Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cells For Patients With Leptomeningeal Melanoma · condition mapped ALIAS · 312 trials mapped (101 active) | — | — | Meningeal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07600476Phase 1 · recruiting A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04588662active not recruiting A Prospective Natural History Study in Uveal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04855435Phase 1 · recruiting Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01979523Phase 2 · active not recruiting Trametinib With or Without GSK2141795 in Treating Patients With Metastatic Uveal Melanoma · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07747935Phase 1/Phase 2 · not yet recruiting Study of Neoadjuvant RBP-01 In Patients With Primary Uveal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03698019Phase 2 · active not recruiting A Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05111574Phase 2 · active not recruiting Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Anal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06007690Phase 3 · active not recruiting A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma · condition mapped ALIAS · 312 trials mapped (101 active) | — | — | Choroid Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01587352Phase 2 · active not recruiting Vorinostat in Treating Patients With Metastatic Melanoma of the Eye · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05282901Phase 2 · completed Efficacy and Safety of Pembrolizumab in Combination With Lenvatinib in Metastatic Uveal MElanoma Patients (PLUME) · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05415072Phase 1/Phase 2 · active not recruiting A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03178123Phase 2 · terminated The Study of JS001 Compared to High-Dose Interferon In Patients With Mucosal Melanoma That Has Been Removed by Surgery · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03417739Phase 2 · terminated A Phase II Study of BVD-523 in Metastatic Uveal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05098210Phase 1 · recruiting Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06626516Phase 1/Phase 2 · recruiting Tebentafusp-tebn With LDT in Metastatic UM · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07230613Phase 2 · recruiting Neo-adjuvant Immunotherapy in Patients With Localized Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06424626Phase 1 · enrolling by invitation A Trial of AK104 or AK112 in Combination With Axitinib in Patients With Metastatic Mucosal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07614828Phase 2 · withdrawn Exploratory Clinical Study of Neoadjuvant Immunotherapy Combined With Chemotherapy in Malignant Melanoma of Nasal and Paranasal Mucosa · condition mapped ALIAS · 312 trials mapped (101 active) | — | — | Head and Neck Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04328844Phase 1 · active not recruiting A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03472586Phase 2 · completed Ipilimumab and Nivolumab With Immunoembolization in Treating Participants With Metastatic Uveal Melanoma in the Liver · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03635632Phase 1 · active not recruiting C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N) · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07501117Phase 1 · recruiting Neoadjuvant Immunotherapy for Patients With High-risk Eye Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06246149Phase 3 · recruiting Adjuvant Tebentafusp in High Risk Ocular Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03175432Phase 2 · active not recruiting Bevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain Metastases · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Intracranial Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07215988recruiting Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01989572Phase 3 · completed Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Iris Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07662694not yet recruiting CLASSIFY-OMM: Multicenter Rare Disease Cohort for T-Stage Reclassification and Molecular Subtyping-Based Precision Therapy in Oral Mucosal Melanoma · condition mapped ALIAS · 312 trials mapped (101 active) | — | — | Head and Neck Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06932757Phase 2 · recruiting Adjuvant Quisinostat in High-Risk Uveal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06940739Phase 1/Phase 2 · recruiting A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Ocular Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05075993Phase 1 · active not recruiting Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06414590Phase 2 · recruiting Neoadjuvant Tebentafusp for Uveal Melanoma · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03947385Phase 1/Phase 2 · recruiting Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06319196Phase 2 · recruiting Clear Me: Interception Trial to Detect and Clear Molecular Residual Disease in Patients With High-risk Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07627698Phase 1/Phase 2 · recruiting Dual-Target CSPG4/GD2 CAR-NK Cells for Advanced Melanoma · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03467516Phase 2 · active not recruiting Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03941379active not recruiting A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma · condition mapped ALIAS · 312 trials mapped (101 active) | — | — | Choroid Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04728633Phase 2 · active not recruiting Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07015190Phase 3 · recruiting Neoadjuvant Darovasertib in Primary Uveal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05187884Phase 2 · completed Neoadjuvant/Adjuvant Trial of Darovasertib in Ocular Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Ocular Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05341349Phase 1 · terminated Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastases · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07203391Phase 1 · recruiting Tebentafusp and Roginolisib in Uveal Melanoma to Prolong T-cell Homeostasis · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05377957active not recruiting Prospective Registration Of Patient Data and Quality of Life in Eye Melanoma Patients · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05170334Phase 2 · active not recruiting Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05496686Phase 1 · active not recruiting Targeted Alpha Particle Radiotherapy for Metastatic Uveal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05628883Phase 1 · completed Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Non-Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06581406Phase 2/Phase 3 · recruiting A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06861647completed iSITE: Investigation of Somatic Alterations in Tumours of the Eye · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Ocular Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07506447completed The Value of [18F]FDG PET/CT Imaging in Prognostic Evaluation of Mucosal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07276386Phase 2 · recruiting Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal Melanoma · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06075589NA · active not recruiting Psychoeducation for Uveal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06550674NA · recruiting Identification of New Candidate Genes for Hereditary Predisposition to Uveal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03070392Phase 2 · completed Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04119024Phase 1 · recruiting Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02068586Phase 2 · active not recruiting Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma · condition mapped ALIAS · 312 trials mapped (101 active) | — | — | Medium/Large Size Posterior Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05907954Phase 2 · active not recruiting (Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07364474NA · recruiting Immune Response to Percutaneous Hepatic Perfusion With Melphalan for Ocular Melanoma Metastatic to the Liver · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02858869Phase 1 · completed Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04792463recruiting Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06627244Phase 2 · recruiting Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06999980Phase 2 · recruiting Neo IRENIE (NEOadjuvant Ipilimumab, RElatlimab, NIvolumab Evaluation) · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07421739recruiting Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects · condition mapped ALIAS · 312 trials mapped (101 active) | — | — | Choroid Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05384496Phase 2 · recruiting Axitinib and Nivolumab for the Treatment of Mucosal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02517736Phase 2 · completed Study Multicentre Evaluating the Effectiveness and Toxicity Sorafenib (Nexavar®) in Adult Patients With Uveal Melanoma and Metastatic Dissemination · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05987332Phase 2/Phase 3 · active not recruiting IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04552223Phase 2 · completed Nivolumab Plus Relatlimab in Patients With Metastatic Uveal Melanoma · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06432660active not recruiting Eye Plaque Brachytherapy for Ocular Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Ocular Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04645680Phase 2 · active not recruiting Diet and Immune Effects Trial: DIET- A Randomized Double Blinded Dietary Intervention Study in Patients With Metastatic Melanoma Receiving Immunotherapy · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01983748Phase 3 · completed Dendritic Cells Plus Autologous Tumor RNA in Uveal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03865212Phase 1 · terminated Modified Virus VSV-IFNbetaTYRP1 in Treating Patients With Stage III-IV Melanoma · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Choroid Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06717126Phase 2 · active not recruiting A Randomised Phase II Study of Roginolisib in Patients With Advanced/Metastatic Uveal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07347444Phase 2 · not yet recruiting Iparomlimab and Tuvoraleimab Injection in Combination With Bevacizumab, Albumin-bound Paclitaxel, and Carboplatin as First- or Second-line Treatment for Patients With Advanced Acral and Mucosal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07336979Phase 2 · recruiting Paclitaxel Polymersomes + Carboplatin + Adebelimab: Neoadjuvant Phase Ⅱ Single-Arm Study for Resectable Mucosal Melanoma · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03746431Phase 1 · terminated A Phase 1 Study of [225Ac]-FPI-1434 Injection · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06022029Phase 1 · recruiting A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04082962Phase 1 · completed Dexamethasone Implant for Retinal Detachment in Uveal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06121180Phase 2 · recruiting Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07136181Phase 1/Phase 2 · recruiting Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01334008NA · completed Study of Circulating Tumoral DNA in Metastatic Choroidal Melanoma · condition mapped ALIAS · 312 trials mapped (101 active) | — | — | Choroid Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06784648Phase 1/Phase 2 · active not recruiting Different Doses of BI-1607 in Combination With Pembrolizumab and Ipilimumab, in Participants With Unresectable or Metastatic Melanoma · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07236528Phase 2 · not yet recruiting Combination of Carilizumab, Apatinib, and Radiotherapy for Advanced Mucosal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05812027active not recruiting A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01473004Phase 2 · completed SIR-Spheres® 90Y Microspheres Treatment of Uveal Melanoma Metastasized to Liver · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07155317Phase 2 · recruiting Time-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME Trial · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04935229Phase 1 · terminated Intrahepatic Delivery of SD-101 by Pressure-Enabled Regional Immuno-oncology (PERIO), With Checkpoint Blockade in Adults With Metastatic Uveal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03712904Phase 2 · terminated Stereotactic Body Radiation Therapy and Aflibercept in Treating Patients With Uveal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06805825Phase 1 · recruiting A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04812470Phase 1 · completed Hepatic Arterial Infusion of Autologous Tumor Infiltrating Lymphocytes in Patients With Melanoma and Liver Metastases · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02849145NA · completed Evaluation Interest of the Circulating Tumor DNA Dosage in Patient With Hepatic Metastatic Uveal Melanoma Candidate to Complete Resection (ct DNA R0) · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04118062NA · completed Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR) · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05893654Phase 1/Phase 2 · enrolling by invitation Melphalan Chemoreduction for Ocular Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04283890Phase 1/Phase 2 · active not recruiting PHP and Immunotherapy in Metastasized UM · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04728113NA · completed Early Integration of Supportive Care for Metastatic Uveal Melanoma Patients (EarlyTogether) · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04424719NA · recruiting Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME) · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05004025Phase 1 · completed Single Arm Trial of Tumor-Treating Fields in Combination With Nivolumab and Ipilimumab in Metastatic Uveal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03964298completed Study of the Activity of PD-1 Inhibitors in Metastatic Uveal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02874040NA · completed Endoresection of the Tumor Scar or Transpupillary Thermotherapy for the Treatment of Large Uveal Melanomas (Endoresection-Laser) · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03611868Phase 1/Phase 2 · active not recruiting A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05315258Phase 2 · active not recruiting Tebentafusp in Molecular Relapsed Disease (MRD) Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04720417Phase 2 · terminated Defactinib and VS-6766 for the Treatment of Patients With Metastatic Uveal Melanoma · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07063875Phase 1/Phase 2 · recruiting Adding IL-2 to Tebentafusp to Eradicate Cancer Progression · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05086692Phase 1/Phase 2 · recruiting A Beta-only IL-2 ImmunoTherapY Study · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04830124Phase 2 · terminated Nemvaleukin Alfa Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Cutaneous or Mucosal Melanoma - ARTISTRY-6 · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06970236NA · recruiting Resistance Exercise in Patients With Ocular Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Ocular Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00661622Phase 2 · completed Halt Growth of Liver Tumors From Uveal Melanoma With Closure of Liver Artery Following Injection of GM-CSF · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03922880Phase 1 · completed Study of Immunotherapy Plus ADI-PEG 20 for the Treatment of Advanced Uveal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05502900Phase 3 · recruiting Adjuvant Melatonin for Uveal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01355120Phase 2 · completed THE IPI - Trial in Advanced Melanoma: Melanoma Patients With Advanced Disease · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Ocular Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05436990Phase 2 · terminated Antitumor Activity of Vactosertib in Combination With Pembrolizumab in Acral and Mucosal Melanoma Patients Progressed From Prior Immune Check Point Inhibitor · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04463368Phase 1 · completed Isolated Hepatic Perfusion in Combination With Ipilimumab and Nivolumab in Patients With Uveal Melanoma Metastases · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03172299Phase 3 · completed Prevention of Neovascular Glaucoma by Intravitreal Injections of Anti-VEGF in Patients Treated with Proton Therapy for a Large Choroidal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Ocular Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04802876Phase 2 · active not recruiting Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05576077Phase 1 · terminated A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06863870active not recruiting Assessment of Circulating Tumor Cells and microRNAs in Patients With Metastatic Non-cutaneous Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04417530Phase 2 · completed Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01338389NA · completed Influence of Oral Treatment With Citicoline for the Prevention of Radiation Optic Neuropathy in Patients Treated for Uveal Melanomas With Proton Beam Therapy · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02936388Phase 2 · completed Transarterial Radioembolisation in Comparison to Transarterial Chemoembolisation in Uveal Melanoma Liver Metastasis · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03033576Phase 2 · completed Testing Treatment With Ipilimumab and Nivolumab Compared to Treatment With Ipilimumab Alone in Advanced Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05420324Phase 2 · completed A Study to Assess YH003 in Combination with Pebolizumab and Albumin Paclitaxel Injection in Subjects with Unresectable/metastatic Mucosal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06519266Phase 3 · recruiting PHP in Combination With IPI1/NIVO3 Compared to IPI3/NIVO1 Only in Patients With Uveal Melanoma Liver Metastases · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05169957Phase 1 · completed Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I) · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Ocular Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05797415recruiting Sentinel Lymph Node Biopsy in Ocular Surface and Adnexal Cancers · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Conjunctival Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03319693completed Molecular Characterization of Primary Mucosal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04364230Phase 1/Phase 2 · completed Melanoma Vaccine Against Neoantigen and Shared Antigens by CD40 Activation and TLR Agonists In Patients With Melanoma (Including Ocular Melanoma) · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Ocular Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01585194Phase 2 · completed Nivolumab and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05545969Phase 2 · withdrawn Neoadjuvant Pembrolizumab and Lenvatinib for Mucosal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04879017Phase 1 · terminated FHD-286 in Subjects With Metastatic Uveal Melanoma · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02519322Phase 2 · completed Neoadjuvant and Adjuvant Checkpoint Blockade · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00445965Phase 2 · completed Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer · condition mapped ALIAS · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02978443Phase 2 · terminated A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06280040unknown Longitudinal Follow-Up of Patients Treated With Hypofractionated Stereotactic Photon Radiotherapy Due to Uveal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04879654Phase 2 · unknown Toripalimab Combined With Radiotherapy and Chemotherapy in the Treatment of SNMM After Endoscopic Surgery · condition mapped ALIAS · 312 trials mapped (101 active) | — | — | Sinonasal Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00020475Phase 2 · completed Vaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye · condition mapped ALIAS · 312 trials mapped (101 active) | — | — | Ocular Melanoma with Extraocular Extension | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06284512unknown Uveal Melanoma - Comparative Study · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02126579Phase 1/Phase 2 · completed Phase I/II Trial of a Long Peptide Vaccine (LPV7) Plus TLR Agonists · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03052127Phase 1/Phase 2 · completed Study in Subjects With Small Primary Choroidal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02875652NA · completed Circulating Tumoral DNA in Choroidal Melanoma (ctDNA MU) · condition mapped ALIAS · 312 trials mapped (101 active) | — | — | Choroid Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03068624Phase 1 · unknown Autologous CD8+ SLC45A2-Specific T Lymphocytes With Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05482074Phase 2 · withdrawn Olaparib in Unresectable/Metastatic Melanoma With BRCA1/2 · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05022901Phase 3 · active not recruiting An Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in Patients With Hepatic Dominant Ocular Melanoma · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Ocular Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02697630Phase 2 · completed Efficacy Study of Pembrolizumab With Entinostat to Treat Metastatic Melanoma of the Eye · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02223819Phase 2 · completed Crizotinib in High-Risk Uveal Melanoma Following Definitive Therapy · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04729543Phase 1/Phase 2 · recruiting MAGE-C2 TCR T Cell Trial to Treat Melanoma and Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04589832Phase 1/Phase 2 · terminated Study of PAC-1 and Entrectinib for Patients With Metastatic Uveal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04904120Phase 1 · completed Targeted Imaging of Melanoma for Alpha-Particle Radiotherapy · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06073548unknown Patient Experience and Quality of Life During the Surveillance Phase of Uveal Melanoma: A Prospective Multi-method Study · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02743611Phase 1/Phase 2 · terminated Safety & Activity of Controllable PRAME-TCR Therapy in Previously Treated AML/MDS or Metastatic Uveal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02831933Phase 2 · terminated Trial of Radiation and Gene Therapy Before Nivolumab for Metastatic Non-Small Cell Lung Carcinoma and Uveal Melanoma · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06041724Phase 2 · unknown Envafolimab Combined With Recombinant Human Endostatin and First-line Chemotherapy Treat of Advanced Mucosal Melanoma · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03207347Phase 2 · completed A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001) · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02768766Phase 1 · completed Intermittent Selumetinib for Uveal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05677373Phase 1/Phase 2 · withdrawn Testing the Safety and Effectiveness of Combining Two Drugs, PLX2853 and Trametinib in the Treatment of Advanced Uveal Melanoma · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02273219Phase 1 · completed Trial of AEB071 in Combination With BYL719 in Patients With Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05266430terminated Prospective Group-Matched Study With Belzupacap Sarotalocan (Bel-sar; AU-011) or Plaque Radiotherapy for Primary Indeterminate Lesions or Choroidal Melanoma (IL/ CM) · condition mapped ALIAS · 312 trials mapped (101 active) | — | — | Choroid Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05984108unknown Clinical, Radiological, Histologic and Molecular Features of a Cohort of Melanocytic Tumors of the Central Nervous System · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Meningeal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02748564Phase 2 · terminated Aldesleukin and Pembrolizumab in Treating Patients With Stage III-IV Melanoma · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Head and Neck Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01955941completed Vascular Response to Brachytherapy Using Functional OCT · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05889481unknown Morphological, Genetic and Tumour Microenvironment Characterisation in Uveal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03408587Phase 1 · completed CAVATAK® and Ipilimumab in Uveal Melanoma Metastatic to the Liver (VLA-024 CLEVER) · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05733728recruiting Retrospective Register for Uveal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03528408Phase 2 · unknown Study of Adjuvant Ipilimumab and Nivolumab in Subjects With High-risk Ocular Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Ocular Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02570308Phase 1/Phase 2 · completed A Study of the Intra-Patient Escalation Dosing Regimen With IMCgp100 in Patients With Advanced Uveal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03241186Phase 2 · active not recruiting Ipilimumab and Nivolumab as Adjuvant Treatment of Mucosal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05077280Phase 2 · unknown A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00986661Phase 1 · unknown A Study to Assess PV-10 Chemoablation of Cancer of the Liver · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Ocular Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04551352Phase 1 · completed A Study of RO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive Melanomas · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02601378Phase 1 · terminated A Phase I Study of LXS196 in Patients With Metastatic Uveal Melanoma. · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02843386Phase 3 · completed Comparison Between Fotemustin to Intensive Surveillance in Patients With High Risk Uveal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01835145Phase 2 · completed Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03297424Phase 1 · completed A Study of PLX2853 in Advanced Malignancies. · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05402059unknown Clinical Outcomes and Biomarkers in Patients With Stage 0-IV Melanoma in Real Clinical Practice · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04353050NA · unknown Atypical MOLes and Melanoma Early Detection Study (MoleMed) · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02376920completed 5 Year Registry Study to Track Clinical Application of DecisionDx-UM Assay Results and Associated Patient Outcomes · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00084656Phase 2 · completed Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma · condition mapped ALIAS · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02626962Phase 2 · completed Trial of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated Metastatic Uveal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01460810NA · completed Safety and Efficacy of Silicone Oil Tamponade for Surgical Attenuation of Radiation Damage in Choroidal Melanoma · condition mapped ALIAS · 312 trials mapped (101 active) | — | — | Choroid Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01930968withdrawn Definity for Ultrasound of Intraocular Tumors · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Ocular Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04180995Phase 2 · unknown Toripalimab in Combination With Axitinib in Patients With Localized Mucosal Melanoma · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04462965Phase 2 · unknown Postoperative Adjuvant Treatment of Completely Resected Mucosal Melanoma Phase II Study · condition mapped ONTOLOGY_EXACT · 312 trials mapped (101 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |